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Chapter 1 gives a short introduction of laparoscopic Total Mesorectal Excision (LTME)
for the treatment of potentially curative rectal cancer. It discusses the aim of this
thesis, which was to evaluate the role of short-term preoperative radiotherapy and
LTME for rectal cancer in terms of feasibility and short-outcome. Furthermore, quality
of life and sexual functioning in male and female patients after LTME were analyzed.
In Chapter 2 we searched the Cochrane Central register of Controlled Trials
(CENTRAL), MEDLINE, EMBASE and Current Contents from 1990 to December 2005
for randomized controlled trials (RCTs), controlled clinical trials or case series which
describe the efficacy and safety of LTME for the treatment of rectal cancer compared
to Open Total Mesorectal Excision (OTME). As only one RCT described primary
outcome, 3-year and 5-year disease-free survival rates, no meta-analyses could be
performed. Instead all relevant studies have been categorized according to the
evidence they provide according to the guidelines for “Levels of Evidence and Grades
of Recommendation” supplied by the “Oxford Centre for Evidence-based Medicine”.
Forty-eight studies were included and analyzed, which together tested 4224 patients
treated by LTME. Three studies were grade 1b (individual randomized trial), 12 grade
2b (individual cohort study), 5 grade 3b (individual case-control study) and 28 grade
4 (case-series).
Although the level of evidence of the included studies was low, this review
provides the best evidence available. No significant differences in terms of disease-free
survival rate, local recurrence rate, mortality, morbidity, anastomotic leakage, resection
margins, or recovered lymph nodes were found. There is evidence that LTME results
in less blood loss, quicker return to normal diet, less pain, less narcotic use and less
immune response. It seems likely that LTME is associated with longer operative time
and higher costs.
Based on the limited evidence of the 48 studies, we conclude that LTME may have
clinical relevant short-term advantages in selected patients with rectal cancer compared
to OTME.
As more patients will survive rectal cancer, quality of life, including sexual and
bladder functioning, is of increasing importance in this group of patients. Theoretically,
due to magnification and good illumination laparoscopy facilitates pelvic dissection
including identification and preservation of the autonomic nerves. In Chapter 3 the
technique for laparoscopic autonomic nerve preserving TME is described.
In Chapter 4 the feasibility and short-term results of LTME after short-term
radiotherapy are presented. Forty-one rectal cancer patients who underwent LTME
were matched with a historical group of 41 patients undergoing OTME. All patients
received short-term radiotherapy.
No differences in mortality, morbidity and anastomotic leakage were observed
between patients undergoing LTME or OTME. Radicality of resection as assessed by
number of harvested lymph nodes or positive resection margins (circumferential and
distal) did not differ between the two groups. LTME was associated with less blood
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loss, a quicker return to normal diet, and a shorter hospital stay compared to OTME. 
We conclude that LTME is feasible and safe and allows radical resection of rectal
cancer comparable with OTME.
In Chapter 5 the macroscopic quality of the resection specimens of patients
undergoing LTME is described. The TME procedure is aimed at the removal of the
rectum with the surrounding fat (mesorectum). The removal of the mesorectum,
including tumour, positive lymph nodes and single tumour cells minimizes the risk on
local recurrence. However, local recurrences do occur after TME, although in much
lower frequencies. By using a three grade scoring system, the quality of the
mesorectum completeness was judged in 25 LTME patients and compared with a
historical group of 25 OTME patients. The two groups were matched for gender and
type of resection (low anterior or abdomino-perineal resection). 
No differences were observed between the LTME and OTME groups. These data
supports the hypothesis that the oncological resection of LTME is feasible and
adequate. LTME can be performed as efficaciously as OTME.
In Chapter 6 we report a prospective study in which Quality of Life (QoL) is assessed
in 51 patients undergoing short-term radiotherapy and LTME for rectal cancer (38 low
anterior resections (LAR) and 13 abdomino-perineal resections (APR). Patients
completed the Medical Outcomes Study Short Form 36 (SF-36) and the European
Organization for the Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-
C38 questionnaires before LTME, at hospital discharge and then at 3, 6, and 12
months postoperatively. The goal of this manuscript was to show how the quality of
life of patients undergoing LTME changes over time. 
Compared with pre-operative scores on the SF-36, patients reported deterioration
in physical functioning, and improved mental functioning at 3 months. Improvement
in emotional wellbeing was reported both on SF-36 and EORTC QLQ-C30. At one
year, improvements in global QoL and symptoms like fatigue, pain and appetite loss
were reported. However, sexual functioning was worse from 3 months onward until
one year after surgery. Patients who underwent LAR experienced less sexual
dysfunction than patients after APR.
In conclusion, we observed a significant decrease in QoL of patients after LTME in
the first months, which returned to preoperative levels or even improved one year
postoperatively. However, sexual functioning remained impaired and was worse in
patients undergoing APR than in those with LAR. 
As more rectal cancer patients can be cured due to the combination of radiotherapy
and TME, there is an increasing number of survivors who are at risk for treatment-
induced somatic and psychological harm. As has been demonstrated in Chapter 6,
sexual dysfunction after LTME is worse in these survivors. For the first time urogenital
functioning after LTME in male patients was assessed by physical and psychological
measurements and the data are reported in Chapter 7. 
Sexual functioning was assessed by the International Index of Erectile Function
(IIEF), pharmaco duplex-ultrasonography of the cavernous arterial blood flow and
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nocturnal penile tumescence and rigidity monitoring (NPTR). Lower urinary tract
symptoms were assessed by the International Prostate Symptom Score (IPSS). 
These investigations were done just before the start of the preoperative
radiotherapy and at fifteen months follow-up.
Nine patients, mean age 60 (50 -78) years, participated. Erectile function was
maintained in 71%, and ejaculation function in 89%. Compared with pre-operative
scores on the IIEF, patients reported a significant deterioration in intercourse
satisfaction only. 
The NPRT parameters duration of erectile episodes, duration of tip rigidity ≥ 60%,
tumescence activity units (TAU) of the tip and TAU base had decreased 15 months
post surgery. According to their IPSS scores patients reported a deterioration in
frequency and quality of life due to urinary symptoms. 
In conclusion, this prospective study demonstrated that sexual morbidity in rectal
cancer patients after short-term radiotherapy and LTME was considerable, but this did
not lead to impaired overall sexual satisfaction. 
In Chapter 8 we assessed sexual dysfunction in women through vaginal
plethysmography, validated questionnaires and in-depth interviews. Four patients
participated, two women after LTME and 2 after OTME. The results were compared
with an age-matched group of 18 healthy women. LTME, OTME patients and healthy
controls showed comparable changes in vaginal vasocongestion during sexual arousal,
though 3 out of 4 patients showed a lower Mean Spectral Tension of the vaginal pulse
compared with healthy controls. Subjective sexual arousal was equivocal between the
three groups. 
Conclusions and future perspectives
The introduction of LTME for primary resectable rectal cancer in Medical Centre
Leeuwarden has led to improved short-term outcome, like less blood loss, a quicker
return to normal diet and a shorter hospital stay compared to historical controls who
underwent OTME. This is in accordance with our systematic review described in
chapter 2 and a recent published meta- analysis both describing LTME under traditional
perioperative treatment for rectal cancer1.
Concomitant with the laparoscopic developments, evidence is accumulating that
accelerated multimodal rehabilitation programs result in significantly improved
postoperative recovery in open colonic surgery2,3. Compared to colonic surgery, rectal
surgery is considered to result in a longer postoperative stay and more morbidity.
There is a lack of evidence regarding the positive effect of accelerated multimodal
rehabilitation programs for OTME. In a recently published randomized clinical trial
enhanced recovery program has been applied comparing laparoscopic and open
surgery for colorectal cancer. In this study of 60 patients, 15 patients with rectal cancer
underwent a laparoscopic resection (12 low anterior resection; 3 abdomoniperineal
resection) and 5 patients underwent open resection (4 low anterior resection; 1
abdominoperineal resection). Despite the small study size, better short-term outcomes
were seen after laparoscopic surgery 4. These data suggest that laparoscopic resection
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of rectal cancer within an enhanced recovery program may provide the best short-
term clinical outcomes for patients with curative rectal cancer. 
Besides the reduced abdominal wall trauma in LTME, less manipulation of abdominal
contents during laparoscopic surgery may diminish inflammatory responses and various
immune functions, although the data are not consistent5. Early physical exercise may
enhance oxygenation of the perineal and wound tissues resulting in improved wound
healing6. Furthermore, a shorter hospital stay may result in improved quality of life and
lower hospital costs. Further randomized controlled trials are required to provide
substantive evidence regarding LTME within an enhanced recovery program. 
In the absence of survival data of LTME, the judgement of the TME resection
specimen can be used as a proxy parameter and provides useful information about
the prognosis of the patient. Patients with an incomplete removed mesorectum have
a worse prognosis; more local recurrence distant metatases and worse survival rates7.
Although the results of this study show at least similar surgical completeness after
LTME compared with OTME for T2 and limited T3 rectal tumours, further multicentre,
randomized clinical trials, like the CLASSIC and COLOR2, will determine whether
LTME for curative rectal cancer will be implemented as a standard treatment8. 
Based on imaging T3 tumours with a margin of a few mm are considered as
advanced tumours9. These tumours need a long- course radiotherapy followed with
a TME procedure after a waiting period of 6 weeks. In our study these tumours were
not included but based on our experience this could be possible since the procedure
of advanced T3 tumours after long- course preoperative treatment is the same as
limited T3 tumours after short- course preoperative treatment. 
A known T4 rectal cancer may prompt an open approach after neoadjuvant
chemoradiotherapy10. When the goal is curative resection, intraoperative discovery of
a T4 lesion requires conversion or a waiting period in case of short-course radiotherapy.
In spite of local control advantage and lack of survival benefit in the Dutch TME
trial, all patients cannot be offered the combination of preoperative radiotherapy and
LTME without placing them at risk of developing subsequent complications. In our
view patient selection is vital in finding the right balance between cure and quality of
life in patient with rectal cancer. Better methods of staging may improve selection of
patients for radiotherapy. 
The solution may be found in two directions; the circumferential resection margin
in relation to the local extent of the tumour versus determination of normal and
metastatic lymph nodes. Though there is no consensus on pre-operative imaging, high
spatial resolution MR has emerged as an important tool in determining the
circumferential resection margins in relation to the local extent of the tumour11,12.
Concerning positive node metastases, subgroup analysis of the Dutch TME-trial
suggests that positive node metastases is a significant predictor of the risk of local
recurrence13. As this was found in a subgroup analysis, these results must be evaluated
with caution. Nodal uptake of ultrasmall particles of iron oxide (USPIO) has been
proposed as a method for enabling accurate determination of normal and metastatic
nodes14.
In lower rectal cancer a higher rate of local recurrence is seen due to involved
circumferential resection margins. Operation technique and distance of the tumour
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from the anal verge seem responsible for this phenomenon15. Therefore, sphincter-
saving rectal surgery may not always be the ideal operation for the treatment of low
rectal cancer and probably we should consider more often an abdominoperineal
resection in these cases. 
With the higher survival rate and reduction of local recurrence rate following
radiotherapy and TME, data of Quality of Life (QoL) become more important. In this
study the impact of short-term preoperative radiotherapy and LTME on QoL of patients
with rectal cancer was assessed. One year after LTME we found improvement in some
important QoL outcomes, including global QoL. However, sexual functioning
significantly decreased from 3 months until one year postoperatively and was worse
in patients undergoing APR than in those with LAR. 
Prospective studies are necessary to test the hypothesis whether QoL after LTME
is superior to QoL after OTME. Meanwhile, extensive pretreatment information and
counseling is necessary regarding good QoL prospective with probably worse sexual
functioning after both LTME as OTME. This information supply may contribute to the
improvement of quality of life after treatment of rectal cancer as symptoms may be
better tolerated if they can be anticipated upon.
Increased fecal incontinence rates in irradiated patients compared to patients who
underwent TME alone is reported after OTME16. In our study, however, we did not
assess the fecal continence. It is important to distinguish which of the two treatments,
preoperative radiotherapy or LTME, is the major causative factor for poor function. As
all patients in our study received radiotherapy we could not identify the contribution
of each treatment component in the development of sexual dysfunction one year
postoperatively. A multicentre randomized trial comparing short-term preoperative
radiotherapy on QoL and sexual functioning in OTME rectal cancer patients describes
that short-term radiotherapy leads to more sexual dysfunction postoperatively, but this
did not lead to significant worse QoL17. In this study they used the Rotterdam Symptom
Check List (RSCL), a cancer-specific questionnaire, supplemented with questions on
sexual functioning, because the RSCL does not include all specific symptoms related
to rectal cancer. As the questions on sexual functioning were not validated the
interpretation of the outcome in this study remains uncertain. In future, sexual
function should preferably be investigated through validated questionnaires like the
Female Sexual Function Index (FSFI)18 for female patients, the International Index of
Erectile Function (IEFF)19 and the International Prostate Symptom Score (IPSS)20 for
male patients. 
Regarding sexual and bladder dysfunction in rectal patients, it is still obscure which
specific psychophysiological mechanisms play a role in male and female urogenital
response. In our study we found for both male and female patients worse objectively
assessed physical sexual dysfunction. In male patients this did not lead to impaired
overall sexual satisfaction and in female patients this did not affect the sexual
relationship negatively. This suggests that psychological factors play probably a more
determining role than physical variables in sexual functioning in patients after LTME. 
Nerve stimulation with tumescence monitoring is an aid although it does not
replace surgical judgement or experience. The success of potency preservation is a
function of patient age and pretreatment erectile function, as well as surgical technique. 
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In recognition of the neurogenic basis for erectile dysfunction after surgery in the
lower pelvis, new strategies have been devised, such as cavernous nerve graft
interposition procedures21,22,23. The grafted nerve serves primarily as a channel of
scaffold for regenerating axons to re-establish connection between the severed
segments. Until now there is only limited experience after radical prostatectomy with
this technique. Furthermore many patients who are not candidates for preservation
of the cavernous nerves have advanced tumours that might require neo-adjuvant
treatment, such as long-course preoperative radiotherapy. In this circumstance, nerve
grafting might provide no worthwhile advantage. The use of cavernous nerve
stimulation may enhance the nerve graft procedure by permitting more precise
identification of the nerve fibres.
Finally, more detailed knowledge regarding the pelvic autonomic nerves below the
inferior hypogastric plexus is needed. Knowledge of the course of these nerves may
contribute to preservation of these nerves24 like in urological surgery were newer
modifications of the radical prostatectomy with nerve-sparing techniques are the
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